\-\ Texto\\:\\ \ \(0\)\
\-\ unknown\ \(157\)\
\-\ patient\\ is\\ asymptomatic\\ and\\ does\\ not\\ require\\ follow\\ up\\.\ \(0\)\
\-\ \\>\\>triple\\ phase\\ hepatic\\ ct\\ scan\\ demonstrated\\ early\\ homogeneous\\ contrast\\ enhancement\\ of\\ mass\\.\\ howver\\ centripetal\\ filling\\ was\\ not\\ completed\\ during\\ the\\ delayed\\ imaging\\.\\ consequently\\,\\ the\\ patient\\ was\\ referred\\ for\\ nuclear\\ medicine\\ tagged\\-rbc\\ for\\ further\\ evaluation\\.\ \(0\)\
\-\ \\>\\>\\ nuclear\\ medicine\\ tagged\\-rbc\\ scan\\ demonstrated\\ rbc\\ localization\\ to\\ lesion\\ and\\ persistence\\ of\\ activity\\ within\\ the\\ lesion\\ on\\ delayed\\ spect\\ imaging\\ compatible\\ with\\ a\\ hemangioma\\.\ \(0\)\
\-\ liver\\ hemangioma\ \(2\)\
\-\ hepatoma\\ \ \(0\)\
\-\ focal\\ nodular\\ hyperplasia\ \(9\)\
\-\ hepatic\\ adenoma\ \(5\)\
\-\ hypervascular\\ metastases\\ \ \(1\)\
\-\ hepatic\\ hemangioma\ \(3\)\
\-\ 50\\ yo\\ male\\ with\\ incidental\\ finding\\ of\\ liver\\ mass\\ during\\ recent\\ laparascopic\\ cholecystectomy\\.\ \(1\)\
\-\ pt\\ then\\ referred\\ for\\ further\\ diagnostic\\ imaging\\ evaluation\\.\ \(0\)\
\-\ while\\ ct\\ scan\\ is\\ a\\ good\\ diagnostic\\ imaging\\ modality\\ for\\ liver\\ lesions\\ \\(e\\.g\\.\\ diagnosis\\ of\\ hemangioma\\ with\\ over\\ 80\\%\\ specificity\\ and\\ sensitivity\\)\\,\\ it\\ can\\ be\\ equivocal\\,\\ parfticularly\\ if\\ the\\ lesion\\ is\\ large\\ with\\ central\\ thrombus\\ which\\ will\\ not\\ opacify\\ after\\ intravenous\\ contrast\\ administration\\.\\ \ \(0\)\
\-\ nuclear\\ medicine\\ technetium\\-99m\\ tagged\\ red\\ blood\\ cell\\ scan\\ demonstrated\\ rbc\\ activity\\ within\\ the\\ lesion\\ on\\ tomographic\\ spect\\ images\\ and\\ proved\\ the\\ diagnosis\\ of\\ hemangioma\\ thus\\ excluding\\ the\\ need\\ for\\ further\\ diagnostic\\ query\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hemangioma\\:\\ 0\\.0974057691378159\ \(0\)\
\-\ tagged\\-rbc\\:\\ 0\\.0899542696323112\ \(0\)\
\-\ nuclear\\:\\ 0\\.06748162005156497\ \(0\)\
\-\ medicine\\:\\ 0\\.062040987079113395\ \(0\)\
\-\ spect\\:\\ 0\\.05795943069425866\ \(0\)\
\-\ \\>\\:\\ 0\\.057942194176909476\ \(0\)\
\-\ hepatic\\:\\ 0\\.054619811507234876\ \(0\)\
\-\ diagnostic\\:\\ 0\\.05182917543385802\ \(0\)\
\-\ rbc\\:\\ 0\\.050241817610774196\ \(0\)\
\-\ scan\\:\\ 0\\.04882186653944853\ \(0\)\
\-\ liver\\:\\ 0\\.04509522720662332\ \(0\)\
\-\ howver\\:\\ 0\\.0449771348161556\ \(0\)\
\-\ parfticularly\\:\\ 0\\.0449771348161556\ \(0\)\
\-\ further\\:\\ 0\\.04159353278265701\ \(0\)\
\-\ opacify\\:\\ 0\\.04144066960921711\ \(0\)\
\-\ query\\:\\ 0\\.04144066960921711\ \(0\)\
\-\ imaging\\:\\ 0\\.04085864947868577\ \(0\)\
\-\ demonstrated\\:\\ 0\\.0383788772825046\ \(0\)\
\-\ laparascopic\\:\\ 0\\.03790420440227861\ \(0\)\
\-\ centripetal\\:\\ 0\\.035835504871114504\ \(0\)\
\-\ lesion\\:\\ 0\\.03552153522449907\ \(0\)\
\-\ delayed\\:\\ 0\\.035489595349644694\ \(0\)\
\-\ hepatoma\\:\\ 0\\.035049021810771346\ \(0\)\
\-\ excluding\\:\\ 0\\.035049021810771346\ \(0\)\
\-\ technetium\\-99m\\:\\ 0\\.03436773919534011\ \(0\)\
\-\ referred\\:\\ 0\\.03290338207607797\ \(0\)\
\-\ activity\\:\\ 0\\.03271476151817896\ \(0\)\
\-\ consequently\\:\\ 0\\.03229903966417601\ \(0\)\
\-\ tagged\\:\\ 0\\.031160552157470853\ \(0\)\
\-\ equivocal\\:\\ 0\\.0299544869632656\ \(0\)\
\-\ tomographic\\:\\ 0\\.0299544869632656\ \(0\)\
\-\ triple\\:\\ 0\\.029443857072668746\ \(0\)\
\-\ persistence\\:\\ 0\\.02897971534712933\ \(0\)\
\-\ proved\\:\\ 0\\.028554298974991312\ \(0\)\
\-\ localization\\:\\ 0\\.028354193295637833\ \(0\)\
\-\ specificity\\:\\ 0\\.028354193295637833\ \(0\)\
\-\ during\\:\\ 0\\.026683767856365385\ \(0\)\
\-\ hypervascular\\:\\ 0\\.025787338307514975\ \(0\)\
\-\ evaluation\\:\\ 0\\.025328967304355177\ \(0\)\
\-\ completed\\:\\ 0\\.025120908805387098\ \(0\)\
\-\ sensitivity\\:\\ 0\\.024625175394909302\ \(0\)\
\-\ compatible\\:\\ 0\\.024087621743593864\ \(0\)\
\-\ modality\\:\\ 0\\.02392032672919085\ \(0\)\
\-\ cholecystectomy\\:\\ 0\\.02330113868325071\ \(0\)\
\-\ e\\.g\\:\\ 0\\.023087035626622995\ \(0\)\
\-\ red\\:\\ 0\\.022749028557535238\ \(0\)\
\-\ thrombus\\:\\ 0\\.02201892221242976\ \(0\)\
\-\ need\\:\\ 0\\.021743069042683454\ \(0\)\
\-\ thus\\:\\ 0\\.02168964404336052\ \(0\)\
\-\ intravenous\\:\\ 0\\.021636772680934262\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.02148136856111432\ \(0\)\
\-\ homogeneous\\:\\ 0\\.02063690714031037\ \(0\)\
\-\ phase\\:\\ 0\\.020508815705968145\ \(0\)\
\-\ 80\\:\\ 0\\.020508815705968145\ \(0\)\
\-\ diagnosis\\:\\ 0\\.020022646232453263\ \(0\)\
\-\ require\\:\\ 0\\.019950222681265655\ \(0\)\
\-\ contrast\\:\\ 0\\.01951811925314189\ \(0\)\
\-\ not\\:\\ 0\\.0189002857919684\ \(0\)\
\-\ good\\:\\ 0\\.018655424105877394\ \(0\)\
\-\ metastases\\:\\ 0\\.01862618596960706\ \(0\)\
\-\ for\\:\\ 0\\.01859969766945702\ \(0\)\
\-\ nodular\\:\\ 0\\.018287805138326077\ \(0\)\
\-\ adenoma\\:\\ 0\\.018206603835744958\ \(0\)\
\-\ administration\\:\\ 0\\.018100307473995766\ \(0\)\
\-\ filling\\:\\ 0\\.01755224498103231\ \(0\)\
\-\ unknown\\:\\ 0\\.01701469132971687\ \(0\)\
\-\ within\\:\\ 0\\.01663399396312328\ \(0\)\
\-\ 50\\:\\ 0\\.016586724574713288\ \(0\)\
\-\ incidental\\:\\ 0\\.016509125499899364\ \(0\)\
\-\ pt\\:\\ 0\\.016210019156289553\ \(0\)\
\-\ early\\:\\ 0\\.015944688620624682\ \(0\)\
\-\ then\\:\\ 0\\.015515137134806579\ \(0\)\
\-\ does\\:\\ 0\\.014875617706040848\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.014737716316306566\ \(0\)\
\-\ recent\\:\\ 0\\.014656729841019372\ \(0\)\
\-\ central\\:\\ 0\\.014345057943163056\ \(0\)\
\-\ finding\\:\\ 0\\.014051334209380005\ \(0\)\
\-\ follow\\:\\ 0\\.013853058530338948\ \(0\)\
\-\ while\\:\\ 0\\.013717598162511802\ \(0\)\
\-\ will\\:\\ 0\\.0136402092774446\ \(0\)\
\-\ yo\\:\\ 0\\.013119140425014091\ \(0\)\
\-\ focal\\:\\ 0\\.012451497980297968\ \(0\)\
\-\ ct\\:\\ 0\\.012196976055020846\ \(0\)\
\-\ mass\\:\\ 0\\.012127153132118004\ \(0\)\
\-\ blood\\:\\ 0\\.011900056492394385\ \(0\)\
\-\ if\\:\\ 0\\.011830323641737936\ \(0\)\
\-\ cell\\:\\ 0\\.011776738324395337\ \(0\)\
\-\ up\\:\\ 0\\.011723709954358282\ \(0\)\
\-\ enhancement\\:\\ 0\\.011686167174097121\ \(0\)\
\-\ lesions\\:\\ 0\\.011671227073183407\ \(0\)\
\-\ over\\:\\ 0\\.01110021729663246\ \(0\)\
\-\ \\%\\:\\ 0\\.010170005272173507\ \(0\)\
\-\ was\\:\\ 0\\.010084464512384558\ \(0\)\
\-\ can\\:\\ 0\\.00988888955341362\ \(0\)\
\-\ it\\:\\ 0\\.00980024685986233\ \(0\)\
\-\ large\\:\\ 0\\.009533379754240201\ \(0\)\
\-\ after\\:\\ 0\\.009020414299026542\ \(0\)\
\-\ patient\\:\\ 0\\.008740733988942734\ \(0\)\
\-\ is\\:\\ 0\\.008606491505888658\ \(0\)\
\-\ images\\:\\ 0\\.008363591285455888\ \(0\)\
\-\ which\\:\\ 0\\.008138492792053819\ \(0\)\
\-\ male\\:\\ 0\\.007883701723915679\ \(0\)\
\-\ on\\:\\ 0\\.007386642983320694\ \(0\)\
\-\ be\\:\\ 0\\.006723248588489434\ \(0\)\
\-\ the\\:\\ 0\\.004937474453700921\ \(0\)\
\-\ \\,\\:\\ 0\\.004143521410978889\ \(0\)\
\-\ a\\:\\ 0\\.004046936753251033\ \(0\)\
\-\ \\(\\:\\ 0\\.0036855190114482676\ \(0\)\
\-\ and\\:\\ 0\\.0036736531782085398\ \(0\)\
\-\ \\)\\:\\ 0\\.0036404984291495157\ \(0\)\
\-\ of\\:\\ 0\\.002972035734642562\ \(0\)\
\-\ with\\:\\ 0\\.0023878403283650964\ \(0\)\
\-\ to\\:\\ 0\\.0021789189206274807\ \(0\)\
\-\ \\.\\:\\ 0\\.0018112008212931774\ \(0\)\
